Anuh Pharma Ltd Gains 0.25% Today Amid Broader Market Decline, Faces 22.05% Three-Month Drop

Anuh Pharma Ltd is currently witnessing strong buying activity, with the stock showing a modest gain of 0.25% today, contrasting with the Sensex’s decline of 0.14%. Over the past week, Anuh Pharma has recorded a total increase of 0.66%, outperforming the Sensex, which rose by 0.55%. However, the stock’s performance over the longer term reveals challenges, with a 3-month decline of 22.05% compared to the Sensex’s drop of 2.85%.

Despite the recent uptick, Anuh Pharma’s year-to-date performance remains negative at -26.12%, while the Sensex has gained 3.49% during the same period. The stock has not experienced any consecutive gains recently, maintaining a flat return of 0% over the last few days.

Price summary indicates that Anuh Pharma opened with a gap up, but it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. The buying pressure may be attributed to market sentiment or specific developments within the pharmaceutical sector, although no specific events have been detailed.

Related Posts

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad